Wat is de prijs voor Synmosa Biopharma Corporation (4114)

Het prijs van Synmosa Biopharma Corporation (4114) is $0.94761103

Wat is de marktkapitalisatie voor Synmosa Biopharma Corporation (4114)

Marktkapitalisatie voorSynmosa Biopharma Corporation (4114) is $511.40M

Synmosa Biopharma Corporation (4114) K/O-verhouding

Synmosa Biopharma Corporation, established in Taipei, Taiwan, in 1980, operates as a dedicated specialty pharmaceutical enterprise. The company manages the entire lifecycle of pharmaceutical and healthcare products, from research and development to manufacturing, marketing, and distribution, primarily serving the Taiwanese market under its proprietary Synmosa brand. Its diverse product portfolio addresses key therapeutic categories, including cardiovascular health, respiratory conditions, urology, sex hormone treatments, and oncology. These offerings are available in various formats such as effervescent tablets, granules, nasal sprays, metered-dose inhalers, hormonal preparations, and other specialized forms. Beyond its proprietary products, Synmosa also extends its expertise through contract manufacturing services. The company maintains a significant international presence, exporting its goods to numerous countries including South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.

Jaar	P/S-ratio	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

P/S-ratio

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	P/S-ratio	Verschil in P/S-ratio	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	-	IN
Galderma Group AG GALD.SW	-	-	CH

Bedrijf

P/S-ratio

Verschil in P/S-ratio

Land